SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-04-007271
Filing Date
2004-03-12
Accepted
2004-03-12 17:31:08
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a04-2995_110k.htm 10-K 1505326
3 EX-10.48 a04-2995_1ex10d48.htm EX-10.48 201406
4 EX-10.49 a04-2995_1ex10d49.htm EX-10.49 149206
5 EX-10.50 a04-2995_1ex10d50.htm EX-10.50 100845
6 EX-10.51 a04-2995_1ex10d51.htm EX-10.51 352497
7 EX-23.1 a04-2995_1ex23d1.htm EX-23.1 3060
8 EX-31.1 a04-2995_1ex31d1.htm EX-31.1 11834
9 EX-31.2 a04-2995_1ex31d2.htm EX-31.2 11947
10 EX-32.1 a04-2995_1ex32d1.htm EX-32.1 7916
  Complete submission text file 0001104659-04-007271.txt   2346491
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19700 | Film No.: 04667144
SIC: 2834 Pharmaceutical Preparations